Physician profile
Cassandra E Slaymaker
NPI 1649759051
$2,680.74
in general payments reported to CMS, 2019-2025
14 companies · $521 in 2025
The $521 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $184 · 2022: $561 · 2023: $1,169 · 2024: $245 · 2025: $521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,041 · Travel and Lodging: $886 · Education: $9.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,040.73 |
| Travel and Lodging | $885.56 |
| Education | $9.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,053.39 | 2023-2025 | Corevalve Evolut R |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $495.88 | 2021-2025 | Lifevest |
| Boston Scientific Corporation | $327.55 | 2022-2025 | Watchman Flx |
| Novartis Pharmaceuticals Corporation | $296.31 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $175.40 | 2022-2025 | Eliquis |
| Kestra Medical Technology Services, INC. | $68.86 | 2023 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $66.00 | 2022-2024 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.94 | 2022 | |
| Merck Sharp & Dohme LLC | $41.57 | 2024-2025 | Verquvo |
| Pfizer INC. | $26.13 | 2021-2025 | |
| Lexicon Pharmaceuticals, INC. | $20.49 | 2023 | Inpefa |
| Amgen INC. | $17.76 | 2021 | |
| Novo Nordisk INC | $17.60 | 2025 | Wegovy |
| Irhythm Technologies, INC. | $14.86 | 2024 | Zio Xt Patch, Zio Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cassandra Slaymaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.